Infinity Pharmaceuticals, Inc. Logo

Infinity Announces Conference Call Discussing Fourth Quarter and Year End 2007 Results

Print
| Source: Infinity Pharmaceuticals, Inc.

CAMBRIDGE, Mass., Feb. 7, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Infinity management will host a conference call on Thursday, February 14, 2008 at 8:30 a.m. EST. In the conference call, management will provide a research and development update and discuss results for the quarter ended December 31, 2007.

To participate in the conference call, please dial 1-800-634-6308 (domestic) and 1-719-325-4940 (international) five minutes prior to the start time. A live webcast of the conference call can be accessed in the Investor section of Infinity's website at www.infi.com. An archived version of the webcast will be available on Infinity's website for 30 days.

About Infinity Pharmaceuticals, Inc.

Infinity is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. For more information on Infinity, please refer to the company's website at http://www.infi.com.

INFI-G

Infinity Pharmaceuticals, Inc.
Investor and Media Contact:
Monique Allaire
617.453.1105